INS and metabolic syndrome: Produced primarily in the liver, this multifunctional glycoprotein has been implicated in the regulation of insulin sensitivity, inflammatory processes, and lipid metabolism, which places it as a plausible contributor to the pathophysiology of dyslipidemia and related disorders.